A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)

著者: Kenneth Kalunian, Joan T. Merrill, Romeo Maciuca, Jacqueline McBride, Michael J. Townsend, Xiaohui Wei, John C. Davis, William P. Kennedy - Annals of the Rheumatic Diseases 2015 被引用: 339